Clinical and patient-reported outcomes of microneedling with ascorbic acid versus scalpel technique for gingival depigmentation: A randomized clinical trial Authors: Anika Dawar, Jaya Pandey, Vikender Singh Yadav, Dolly Angral, Sumit Kumar Das, Anuppriyanka Ilango, Razia Haidrus Published: 2026 ABSTRACT ObjectivesTo compare gingival depigmentation achieved with microneedling and topical ascorbic acid (MN + AA) versus the conventional scalpel technique, along with evaluation of repigmentation and patient-reported outcomes (PROMs). Gingival thickness (GT) and dermal-gingival pigmentation associations were also explored.MethodsTwenty-six participants with maxillary physiologic gingival hyperpigmentation were randomized (1:1) to scalpel or MN + AA using an automated microneedling pen. Gingival pigmentation was assessed clinically (Dummett-Gupta Oral Pigmentation Index [DOPI], Gingival Pigmentation Index [GPI]); photographically (Pigmented Surface Area [PSA], Lightness [L]), and using a melanin meter (Gingival Melanin Meter Score, GMMS) at baseline, 1, 3, and 6 months. Primary outcome was change in DOPI at 1 month. Gingival Thickness (GT) and Dermal Melanin Meter Scores (DMMS) were recorded.ResultsTwenty-three participants completed the study. The scalpel group showed greater reduction in DOPI, GPI, PSA, GMMS, and a greater increase in L at 1 month (P < 0.05). Incomplete depigmentation was observed at some gingival sites with MN + AA. Repigmentation occurred in both groups; DOPI and GMMS were significantly lower in scalpel group at 3 months, with the difference in DOPI persisting at 6 months. Pain, itching, and discomfort scores were modestly higher in the scalpel group, with significant for discomfort on day 3. Color improvement and satisfaction scores were high in both groups. GT increased significantly in the MN + AA at 6 months. DMMS and GMMS were not correlated at any timepoint.ConclusionBoth treatments significantly reduced gingival pigmentation at 1 month, with the scalpel technique showing lower pigmentation intensity at 6 months. Both treatments were well tolerated with favorable PROMs.Clinical trial registration numberCTRI/2024/05/066602 (ctri.nic.in) Introduction Gingival color is an important determinant of smile esthetics. Physiological gingival hyperpigmentation is a brownish discoloration of the gingiva resulting from an increased melanin deposition by the melanocytes within the basal and suprabasal epithelial layers.1 Gingival depigmentation is a periodontal plastic procedure frequently sought by patients to improve the smile esthetics. Conventional techniques achieve this by removing the pigmented epithelial layer, allowing regeneration of less pigmented tissues, with commonly used modalities including scalpel surgery, laser ablation, bur abrasion, and electrocautery.2 Among these, scalpel depigmentation remains the gold standard owing to its simplicity, affordability, and predictable outcomes. However, surgical procedures are associated with disadvantages such as intraoperative bleeding, post-operative pain, delayed wound healing, patient discomfort, recurrence of pigmentation, and may be challenging in patients with a thin gingival phenotype because of the risk of gingival recession, injury to periosteum, or bone exposure.1,3 These limitations warrant exploration of other non-surgical alternatives. Among the minimally invasive approaches, ascorbic acid (AA)/vitamin C, a widely used dermal depigmentation agent, has emerged as a promising option for gingival depigmentation.4,5 AA inhibits melanogenesis by reducing tyrosinase activity, thereby reducing dopaquinone formation, a key intermediate in melanin synthesis. Its antioxidant and reducing properties decrease melanocyte activity and convert oxidized melanin to lighter forms. It also interferes with melanosome transfer by modulating melanocyte-keratinocyte interactions and promoting collagen synthesis, making it suitable for gingival application.1,6,7 Both topical and injectable AA formulations have been explored for gingival depigmentation 1,6, 7, 8, 9, 10, 11. While topical application is simple and painless, its effectiveness may be limited by salivary washout and restricted tissue penetration.6 Injectable AA (oral mesotherapy) overcomes these limitations through localized trans-epithelial delivery and has demonstrated depigmentation efficacy comparable to scalpel and laser techniques, with favorable patient-reported outcomes (PROMs) 1,10, 11, 12. However, injectable delivery remains technique-sensitive with limited control over penetration depth, and potential to cause tissue irritation or necrosis with excessive dosage or deeper penetration. Another consideration with conventional needles is product leakage in regions of thin gingival thickness such as canine eminence and the mucogingival junction.1,11 Therefore, a suitable approach for AA delivery in the gingival tissues is warranted, allowing effective tissue penetration with safety and ease of use. In this context, microneedling (MN) is an emerging minimally invasive approach that creates transient microchannels within the epithelium using micron-sized needles.13 These microchannels enhance trans-epithelial delivery of topical agents while providing greater control over penetration depth than conventional injections.Additionally, MN induces collagen synthesis, potentially increasing gingival thickness, and may act synergistically with topical AA to enhance depigmentation 13, 14, 15. Although combination of MN and AA has been widely used in dermatology to treat hyperpigmentation conditions such as melasma,15,16 studies evaluating this intervention for gingival depigmentation are scarce. Previous studies are largely confined to pre- and post-treatment evaluation of MN + AA,17,18 while the few comparisons with the scalpel technique have focussed on short-term depigmentation outcomes assessed using clinical indices alone.19,20 Further, repigmentation, PROMs such as treatment tolerability and satisfaction, and the additional benefits and challenges associated with the dermatology-based MN device have not been evaluated together, precluding an overall assessment of this modality. Thus, the present randomized clinical trial primarily aimed to compare the gingival depigmentation achieved using a dermatology-based MN pen combined with topically applied AA with the conventional scalpel technique. Secondary objectives were to compare gingival repigmentation and PROMs between groups. Additionally, changes in gingival thickness and associations between dermal and gingival pigmentation across treatment groups were also explored. Materials and methods Study design The present study was a parallel-group, single-blinded, randomized controlled clinical trial and conducted in accordance with CONSORT guidelines. Ethical approval was obtained from the institute's ethics committee (AIIMSA1242/22.4.24), and the trial was prospectively registered with the Clinical Trial Registry-India (CTRI/2024/05/066602). Each participant received detailed information regarding the study design and potential risks and benefits, following which written informed consent was obtained. The study adhered to the ethical principles outlined in the Declaration of Helsinki (1975, revised in 2013). Study participants The participants were selected from patients attending the outpatient clinic of the Periodontics Division,Centre for Dental Education and Research, All India Institute of Medical Sciences, New Delhi between May 2024 and April 2025. The participants were included based on the following criteria:(a) adults aged 18-40 years; (b) physiologic melanin hyperpigmentation of the maxillary anterior gingiva; (c) seeking esthetic management of gingival hyperpigmentation, (d) availability for three treatment sessions and follow-up visits; and (e) systemically healthy. Exclusion criteria were: (a) pathologic/drug-induced gingival pigmentation; (b) current or former smokers; (c) presence of periodontal diseases; (d) patients taking AA supplements; (e) known hypersensitivity to AA ; (f) pregnant or lactating females. Sample size Sample size was calculated using the power.t.test function in R statistical software (version 4.6.0). Dummett Gupta oral pigmentation index (DOPI) was considered as the primary outcome. Previous studies have reported the mean ± standard deviation (SD) of DOPI at 1 month ranging from 0.15 ± 0.36 to 1.87 ± 0.38 in the control(scalpel) group, and 1.07 ± 0.31 for the MN + AA group. 15,18 Anticipating a mean difference of 0.6 units at 1 month between the two groups and considering the highest SD of 0.38, the minimum sample size was estimated to be 20 (10 per group) at a 5% level of significance with 90% power. Accounting for a 15% loss to follow-up, the final sample size was estimated at 26 participants (13 per group). Randomization, allocation concealment and blinding Participants meeting the eligibility criteria were randomly allocated (1:1) to the control (scalpel) or the test (MN + AA) group using a computer-generated random sequence (www.randomizer.org). Allocation concealment was achieved using sequentially numbered, opaque, sealed envelopes (SNOSE), prepared by an individual not involved in the trial. Participants were enrolled by investigator DA, while the group allocation was disclosed immediately before treatment by investigator VSY, who was not involved in recruitment, treatment or outcome assessment. The outcome assessor (JP) was blinded to the group allocation; however, blinding of the treating clinician (AD) and the participants was not possible due to the nature of the interventions. Examiner calibration Intra-examiner reliability of the trained blinded outcome assessor (JP) was assessed in five pilot patients not included in the study, with reassessment of all parameters after 1 week. A weighted Cohen's kappa of >0.80 was obtained for clinical pigmentation indices, and an intraclass coefficient of >0.90 for other parameters. Parameters Assessed 1.Gingival melanin pigmentation(1A)Clinical pigmentation indices:•DOPI: Assesses pigmentation intensity and is scored as follows: 0: no pigmentation (pink tissue), 1: mild pigmentation (mild light brown color), 2: moderate pigmentation (medium brown or mixed pink and brown coloration), 3: heavy pigmentation (deep brown or blue-black tissue).•Gingival Pigmentation Index (GPI): Assesses pigmentation extent and is scored as follows: 0: Absence, 1: spots of brown or black, 2: brown or black patches but not diffuse, 3: diffuse brown or black pigmentation(1B)Digital photographic parameters: Standardized digital photographs were taken by a single operator (DA) using the same camera, lighting and patient positioning settings. Images were analyzed using Adobe Photoshop software 2021 (version 22.0, Adobe Inc., USA) to measure the following parameters:•Gingival Lightness (L): Represents the L* coordinate (0 = darkest and 100 = lightest), of the International Commission on Illumination L*a*b* colour order system (CIEL*A*B*) system, with lower values indicating greater pigmentation intensity.21•Pigmented Surface Area (PSA): It was traced using a quick selection tool, with isolated patches assessed individually to calculate the cumulative pigmented area.(1C)Gingival melanin meter score (GMMS): Gingival melanin concentration was objectively quantified using the MILO melanin meter (Forma-TK Limited, Israel), a handheld dermal probe applied non-invasively to the gingival surface. The target pigmented gingiva was dried, and the probe was positioned perpendicular to the attached gingiva, approximately 1.5 mm apical to the gingival margin. A numeric reading (0 to 100) was obtaied, with higher values indicating greater melanin intensity (Fig. 1a and b).Fig. 1Assessment of gingival and dermal melanin concentration, gingival thickness and clinical steps of scalpel gingival depigmentation: (a) Baseline maxillary gingival pigmentation; (b) Recording gingival melanin meter score (GMMS) with the melanin meter probe placed perpendicular to the pigmented gingiva; (c, d) Recording dermal melanin meter score (DMMS) bilaterally at the malar regions; (e) Gingival thickness was assessed using a #20 endodontic spreader inserted perpendicularly through the gingiva until hard tissue contact was achieved, with the insertion depth stabilized using flowable composite; (f) Distance between flowable composite stop and the spreader tip using a digital caliper was measured to obtain gingival thickness; (g) Bard Parker knife with blade no. 15C positioned for a partial-thickness incision in the pigmented gingiva; (h) De-epithelialized gingiva following removal of pigmented epithelium; (i) Clinical appearance at 1-week post-surgery.(2)Dermal melanin pigmentation: Constitutional skin pigmentation was assessed at baseline using:(2A)The Fitzpatrick Skin Type (FST): Skin phototype was classified according to the Fitzpatrick scale, ranging from type I (very fair) to type VI (deeply pigmented).22(2B)Dermal melanin meter score (DMMS): Facial dermal melanin concentration was measured bilaterally at the malar regions using the melanin meter scores as described above (Fig. 1c and d).(3)Gingival thickness (GT): GT was measured at a fixed site,1.5 mm apical to the gingival margin at the mid-buccal aspect of each tooth, using a #20 endodontic spreader inserted perpendicular to the gingival surface until hard tissue was reached. Insertion depth was marked by flowable composite and measured using a digital caliper. (Fig. 1e and f). 1.Gingival melanin pigmentation(1A)Clinical pigmentation indices:•DOPI: Assesses pigmentation intensity and is scored as follows: 0: no pigmentation (pink tissue), 1: mild pigmentation (mild light brown color), 2: moderate pigmentation (medium brown or mixed pink and brown coloration), 3: heavy pigmentation (deep brown or blue-black tissue).•Gingival Pigmentation Index (GPI): Assesses pigmentation extent and is scored as follows: 0: Absence, 1: spots of brown or black, 2: brown or black patches but not diffuse, 3: diffuse brown or black pigmentation(1B)Digital photographic parameters: Standardized digital photographs were taken by a single operator (DA) using the same camera, lighting and patient positioning settings. Images were analyzed using Adobe Photoshop software 2021 (version 22.0, Adobe Inc., USA) to measure the following parameters:•Gingival Lightness (L): Represents the L* coordinate (0 = darkest and 100 = lightest), of the International Commission on Illumination L*a*b* colour order system (CIEL*A*B*) system, with lower values indicating greater pigmentation intensity.21•Pigmented Surface Area (PSA): It was traced using a quick selection tool, with isolated patches assessed individually to calculate the cumulative pigmented area.(1C)Gingival melanin meter score (GMMS): Gingival melanin concentration was objectively quantified using the MILO melanin meter (Forma-TK Limited, Israel), a handheld dermal probe applied non-invasively to the gingival surface. The target pigmented gingiva was dried, and the probe was positioned perpendicular to the attached gingiva, approximately 1.5 mm apical to the gingival margin. A numeric reading (0 to 100) was obtaied, with higher values indicating greater melanin intensity (Fig. 1a and b).Fig. 1Assessment of gingival and dermal melanin concentration, gingival thickness and clinical steps of scalpel gingival depigmentation: (a) Baseline maxillary gingival pigmentation; (b) Recording gingival melanin meter score (GMMS) with the melanin meter probe placed perpendicular to the pigmented gingiva; (c, d) Recording dermal melanin meter score (DMMS) bilaterally at the malar regions; (e) Gingival thickness was assessed using a #20 endodontic spreader inserted perpendicularly through the gingiva until hard tissue contact was achieved, with the insertion depth stabilized using flowable composite; (f) Distance between flowable composite stop and the spreader tip using a digital caliper was measured to obtain gingival thickness; (g) Bard Parker knife with blade no. 15C positioned for a partial-thickness incision in the pigmented gingiva; (h) De-epithelialized gingiva following removal of pigmented epithelium; (i) Clinical appearance at 1-week post-surgery. Gingival melanin pigmentation(1A)Clinical pigmentation indices:•DOPI: Assesses pigmentation intensity and is scored as follows: 0: no pigmentation (pink tissue), 1: mild pigmentation (mild light brown color), 2: moderate pigmentation (medium brown or mixed pink and brown coloration), 3: heavy pigmentation (deep brown or blue-black tissue).•Gingival Pigmentation Index (GPI): Assesses pigmentation extent and is scored as follows: 0: Absence, 1: spots of brown or black, 2: brown or black patches but not diffuse, 3: diffuse brown or black pigmentation(1B)Digital photographic parameters: Standardized digital photographs were taken by a single operator (DA) using the same camera, lighting and patient positioning settings. Images were analyzed using Adobe Photoshop software 2021 (version 22.0, Adobe Inc., USA) to measure the following parameters:•Gingival Lightness (L): Represents the L* coordinate (0 = darkest and 100 = lightest), of the International Commission on Illumination L*a*b* colour order system (CIEL*A*B*) system, with lower values indicating greater pigmentation intensity.21•Pigmented Surface Area (PSA): It was traced using a quick selection tool, with isolated patches assessed individually to calculate the cumulative pigmented area.(1C)Gingival melanin meter score (GMMS): Gingival melanin concentration was objectively quantified using the MILO melanin meter (Forma-TK Limited, Israel), a handheld dermal probe applied non-invasively to the gingival surface. The target pigmented gingiva was dried, and the probe was positioned perpendicular to the attached gingiva, approximately 1.5 mm apical to the gingival margin. A numeric reading (0 to 100) was obtaied, with higher values indicating greater melanin intensity (Fig. 1a and b).Fig. 1Assessment of gingival and dermal melanin concentration, gingival thickness and clinical steps of scalpel gingival depigmentation: (a) Baseline maxillary gingival pigmentation; (b) Recording gingival melanin meter score (GMMS) with the melanin meter probe placed perpendicular to the pigmented gingiva; (c, d) Recording dermal melanin meter score (DMMS) bilaterally at the malar regions; (e) Gingival thickness was assessed using a #20 endodontic spreader inserted perpendicularly through the gingiva until hard tissue contact was achieved, with the insertion depth stabilized using flowable composite; (f) Distance between flowable composite stop and the spreader tip using a digital caliper was measured to obtain gingival thickness; (g) Bard Parker knife with blade no. 15C positioned for a partial-thickness incision in the pigmented gingiva; (h) De-epithelialized gingiva following removal of pigmented epithelium; (i) Clinical appearance at 1-week post-surgery. (1A)Clinical pigmentation indices:•DOPI: Assesses pigmentation intensity and is scored as follows: 0: no pigmentation (pink tissue), 1: mild pigmentation (mild light brown color), 2: moderate pigmentation (medium brown or mixed pink and brown coloration), 3: heavy pigmentation (deep brown or blue-black tissue).•Gingival Pigmentation Index (GPI): Assesses pigmentation extent and is scored as follows: 0: Absence, 1: spots of brown or black, 2: brown or black patches but not diffuse, 3: diffuse brown or black pigmentation Clinical pigmentation indices:•DOPI: Assesses pigmentation intensity and is scored as follows: 0: no pigmentation (pink tissue), 1: mild pigmentation (mild light brown color), 2: moderate pigmentation (medium brown or mixed pink and brown coloration), 3: heavy pigmentation (deep brown or blue-black tissue).•Gingival Pigmentation Index (GPI): Assesses pigmentation extent and is scored as follows: 0: Absence, 1: spots of brown or black, 2: brown or black patches but not diffuse, 3: diffuse brown or black pigmentation •DOPI: Assesses pigmentation intensity and is scored as follows: 0: no pigmentation (pink tissue), 1: mild pigmentation (mild light brown color), 2: moderate pigmentation (medium brown or mixed pink and brown coloration), 3: heavy pigmentation (deep brown or blue-black tissue). DOPI: Assesses pigmentation intensity and is scored as follows: 0: no pigmentation (pink tissue), 1: mild pigmentation (mild light brown color), 2: moderate pigmentation (medium brown or mixed pink and brown coloration), 3: heavy pigmentation (deep brown or blue-black tissue). •Gingival Pigmentation Index (GPI): Assesses pigmentation extent and is scored as follows: 0: Absence, 1: spots of brown or black, 2: brown or black patches but not diffuse, 3: diffuse brown or black pigmentation Gingival Pigmentation Index (GPI): Assesses pigmentation extent and is scored as follows: 0: Absence, 1: spots of brown or black, 2: brown or black patches but not diffuse, 3: diffuse brown or black pigmentation (1B)Digital photographic parameters: Standardized digital photographs were taken by a single operator (DA) using the same camera, lighting and patient positioning settings. Images were analyzed using Adobe Photoshop software 2021 (version 22.0, Adobe Inc., USA) to measure the following parameters:•Gingival Lightness (L): Represents the L* coordinate (0 = darkest and 100 = lightest), of the International Commission on Illumination L*a*b* colour order system (CIEL*A*B*) system, with lower values indicating greater pigmentation intensity.21•Pigmented Surface Area (PSA): It was traced using a quick selection tool, with isolated patches assessed individually to calculate the cumulative pigmented area. Digital photographic parameters: Standardized digital photographs were taken by a single operator (DA) using the same camera, lighting and patient positioning settings. Images were analyzed using Adobe Photoshop software 2021 (version 22.0, Adobe Inc., USA) to measure the following parameters:•Gingival Lightness (L): Represents the L* coordinate (0 = darkest and 100 = lightest), of the International Commission on Illumination L*a*b* colour order system (CIEL*A*B*) system, with lower values indicating greater pigmentation intensity.21•Pigmented Surface Area (PSA): It was traced using a quick selection tool, with isolated patches assessed individually to calculate the cumulative pigmented area. •Gingival Lightness (L): Represents the L* coordinate (0 = darkest and 100 = lightest), of the International Commission on Illumination L*a*b* colour order system (CIEL*A*B*) system, with lower values indicating greater pigmentation intensity.21 Gingival Lightness (L): Represents the L* coordinate (0 = darkest and 100 = lightest), of the International Commission on Illumination L*a*b* colour order system (CIEL*A*B*) system, with lower values indicating greater pigmentation intensity.21 •Pigmented Surface Area (PSA): It was traced using a quick selection tool, with isolated patches assessed individually to calculate the cumulative pigmented area. Pigmented Surface Area (PSA): It was traced using a quick selection tool, with isolated patches assessed individually to calculate the cumulative pigmented area. (1C)Gingival melanin meter score (GMMS): Gingival melanin concentration was objectively quantified using the MILO melanin meter (Forma-TK Limited, Israel), a handheld dermal probe applied non-invasively to the gingival surface. The target pigmented gingiva was dried, and the probe was positioned perpendicular to the attached gingiva, approximately 1.5 mm apical to the gingival margin. A numeric reading (0 to 100) was obtaied, with higher values indicating greater melanin intensity (Fig. 1a and b).Fig. 1Assessment of gingival and dermal melanin concentration, gingival thickness and clinical steps of scalpel gingival depigmentation: (a) Baseline maxillary gingival pigmentation; (b) Recording gingival melanin meter score (GMMS) with the melanin meter probe placed perpendicular to the pigmented gingiva; (c, d) Recording dermal melanin meter score (DMMS) bilaterally at the malar regions; (e) Gingival thickness was assessed using a #20 endodontic spreader inserted perpendicularly through the gingiva until hard tissue contact was achieved, with the insertion depth stabilized using flowable composite; (f) Distance between flowable composite stop and the spreader tip using a digital caliper was measured to obtain gingival thickness; (g) Bard Parker knife with blade no. 15C positioned for a partial-thickness incision in the pigmented gingiva; (h) De-epithelialized gingiva following removal of pigmented epithelium; (i) Clinical appearance at 1-week post-surgery. Gingival melanin meter score (GMMS): Gingival melanin concentration was objectively quantified using the MILO melanin meter (Forma-TK Limited, Israel), a handheld dermal probe applied non-invasively to the gingival surface. The target pigmented gingiva was dried, and the probe was positioned perpendicular to the attached gingiva, approximately 1.5 mm apical to the gingival margin. A numeric reading (0 to 100) was obtaied, with higher values indicating greater melanin intensity (Fig. 1a and b).Fig. 1Assessment of gingival and dermal melanin concentration, gingival thickness and clinical steps of scalpel gingival depigmentation: (a) Baseline maxillary gingival pigmentation; (b) Recording gingival melanin meter score (GMMS) with the melanin meter probe placed perpendicular to the pigmented gingiva; (c, d) Recording dermal melanin meter score (DMMS) bilaterally at the malar regions; (e) Gingival thickness was assessed using a #20 endodontic spreader inserted perpendicularly through the gingiva until hard tissue contact was achieved, with the insertion depth stabilized using flowable composite; (f) Distance between flowable composite stop and the spreader tip using a digital caliper was measured to obtain gingival thickness; (g) Bard Parker knife with blade no. 15C positioned for a partial-thickness incision in the pigmented gingiva; (h) De-epithelialized gingiva following removal of pigmented epithelium; (i) Clinical appearance at 1-week post-surgery. Assessment of gingival and dermal melanin concentration, gingival thickness and clinical steps of scalpel gingival depigmentation: (a) Baseline maxillary gingival pigmentation; (b) Recording gingival melanin meter score (GMMS) with the melanin meter probe placed perpendicular to the pigmented gingiva; (c, d) Recording dermal melanin meter score (DMMS) bilaterally at the malar regions; (e) Gingival thickness was assessed using a #20 endodontic spreader inserted perpendicularly through the gingiva until hard tissue contact was achieved, with the insertion depth stabilized using flowable composite; (f) Distance between flowable composite stop and the spreader tip using a digital caliper was measured to obtain gingival thickness; (g) Bard Parker knife with blade no. 15C positioned for a partial-thickness incision in the pigmented gingiva; (h) De-epithelialized gingiva following removal of pigmented epithelium; (i) Clinical appearance at 1-week post-surgery. (2)Dermal melanin pigmentation: Constitutional skin pigmentation was assessed at baseline using:(2A)The Fitzpatrick Skin Type (FST): Skin phototype was classified according to the Fitzpatrick scale, ranging from type I (very fair) to type VI (deeply pigmented).22(2B)Dermal melanin meter score (DMMS): Facial dermal melanin concentration was measured bilaterally at the malar regions using the melanin meter scores as described above (Fig. 1c and d). Dermal melanin pigmentation: Constitutional skin pigmentation was assessed at baseline using:(2A)The Fitzpatrick Skin Type (FST): Skin phototype was classified according to the Fitzpatrick scale, ranging from type I (very fair) to type VI (deeply pigmented).22(2B)Dermal melanin meter score (DMMS): Facial dermal melanin concentration was measured bilaterally at the malar regions using the melanin meter scores as described above (Fig. 1c and d). (2A)The Fitzpatrick Skin Type (FST): Skin phototype was classified according to the Fitzpatrick scale, ranging from type I (very fair) to type VI (deeply pigmented).22 The Fitzpatrick Skin Type (FST): Skin phototype was classified according to the Fitzpatrick scale, ranging from type I (very fair) to type VI (deeply pigmented).22 (2B)Dermal melanin meter score (DMMS): Facial dermal melanin concentration was measured bilaterally at the malar regions using the melanin meter scores as described above (Fig. 1c and d). Dermal melanin meter score (DMMS): Facial dermal melanin concentration was measured bilaterally at the malar regions using the melanin meter scores as described above (Fig. 1c and d). (3)Gingival thickness (GT): GT was measured at a fixed site,1.5 mm apical to the gingival margin at the mid-buccal aspect of each tooth, using a #20 endodontic spreader inserted perpendicular to the gingival surface until hard tissue was reached. Insertion depth was marked by flowable composite and measured using a digital caliper. (Fig. 1e and f). Gingival thickness (GT): GT was measured at a fixed site,1.5 mm apical to the gingival margin at the mid-buccal aspect of each tooth, using a #20 endodontic spreader inserted perpendicular to the gingival surface until hard tissue was reached. Insertion depth was marked by flowable composite and measured using a digital caliper. (Fig. 1e and f). Notably, except for GPI, which was assessed as a single score for the entire target pigmented region all other gingival pigmentation parameters (DOPI, PSA, L, GMMS) and GT were recorded per tooth, with the mean calculated across the target region. These parameters along with GT, were assessed at baseline and at 1,3 and 6 months post-treatment.(4)PROMs(4A)Pain, itching, discomfort: Participants recorded pain, itching and discomfort using a 10 cm visual analogue scale (VAS; 0 = no symptom, 10 = maximum intensity) separately for each outcome on the day of the procedure (first MN + AA session or scalpel surgery) and daily for 7 days post-procedure. Discomfort was defined as interference with routine oral functions, including eating, smiling, and speaking. Patients were instructed to report any post-operative bleeding or adverse events such as erythema, ulceration, swelling or other post-operative complications.(4B)Perceived gingival color improvement: Participants rated their perceived improvement in gingival color at 1,3 and 6 months post-treatment using a 5-point Likert scale: 0-4 scale: 0: no improvement, 1: little improvement, 2: average improvement, 3: great improvement, 4: Complete improvement(4C)Overall patient satisfaction: It reflected participant's overall treatment experience considering gingival color improvement, pain, itching, discomfort, intra- and post-operative bleeding, interference with routine oral activities, number of treatment visits and experience of undergoing a surgical or non -surgical procedure. Satisfaction was assessed at 1,3 and 6 months post-treatment using a 5-point Likert scale 0-4 scale: 0: very dissatisfied, 1: dissatisfied, 2: neither satisfied nor dissatisfied, 3: satisfied, 4: very satisfied (4)PROMs(4A)Pain, itching, discomfort: Participants recorded pain, itching and discomfort using a 10 cm visual analogue scale (VAS; 0 = no symptom, 10 = maximum intensity) separately for each outcome on the day of the procedure (first MN + AA session or scalpel surgery) and daily for 7 days post-procedure. Discomfort was defined as interference with routine oral functions, including eating, smiling, and speaking. Patients were instructed to report any post-operative bleeding or adverse events such as erythema, ulceration, swelling or other post-operative complications.(4B)Perceived gingival color improvement: Participants rated their perceived improvement in gingival color at 1,3 and 6 months post-treatment using a 5-point Likert scale: 0-4 scale: 0: no improvement, 1: little improvement, 2: average improvement, 3: great improvement, 4: Complete improvement(4C)Overall patient satisfaction: It reflected participant's overall treatment experience considering gingival color improvement, pain, itching, discomfort, intra- and post-operative bleeding, interference with routine oral activities, number of treatment visits and experience of undergoing a surgical or non -surgical procedure. Satisfaction was assessed at 1,3 and 6 months post-treatment using a 5-point Likert scale 0-4 scale: 0: very dissatisfied, 1: dissatisfied, 2: neither satisfied nor dissatisfied, 3: satisfied, 4: very satisfied PROMs(4A)Pain, itching, discomfort: Participants recorded pain, itching and discomfort using a 10 cm visual analogue scale (VAS; 0 = no symptom, 10 = maximum intensity) separately for each outcome on the day of the procedure (first MN + AA session or scalpel surgery) and daily for 7 days post-procedure. Discomfort was defined as interference with routine oral functions, including eating, smiling, and speaking. Patients were instructed to report any post-operative bleeding or adverse events such as erythema, ulceration, swelling or other post-operative complications.(4B)Perceived gingival color improvement: Participants rated their perceived improvement in gingival color at 1,3 and 6 months post-treatment using a 5-point Likert scale: 0-4 scale: 0: no improvement, 1: little improvement, 2: average improvement, 3: great improvement, 4: Complete improvement(4C)Overall patient satisfaction: It reflected participant's overall treatment experience considering gingival color improvement, pain, itching, discomfort, intra- and post-operative bleeding, interference with routine oral activities, number of treatment visits and experience of undergoing a surgical or non -surgical procedure. Satisfaction was assessed at 1,3 and 6 months post-treatment using a 5-point Likert scale 0-4 scale: 0: very dissatisfied, 1: dissatisfied, 2: neither satisfied nor dissatisfied, 3: satisfied, 4: very satisfied (4A)Pain, itching, discomfort: Participants recorded pain, itching and discomfort using a 10 cm visual analogue scale (VAS; 0 = no symptom, 10 = maximum intensity) separately for each outcome on the day of the procedure (first MN + AA session or scalpel surgery) and daily for 7 days post-procedure. Discomfort was defined as interference with routine oral functions, including eating, smiling, and speaking. Patients were instructed to report any post-operative bleeding or adverse events such as erythema, ulceration, swelling or other post-operative complications. Pain, itching, discomfort: Participants recorded pain, itching and discomfort using a 10 cm visual analogue scale (VAS; 0 = no symptom, 10 = maximum intensity) separately for each outcome on the day of the procedure (first MN + AA session or scalpel surgery) and daily for 7 days post-procedure. Discomfort was defined as interference with routine oral functions, including eating, smiling, and speaking. Patients were instructed to report any post-operative bleeding or adverse events such as erythema, ulceration, swelling or other post-operative complications. (4B)Perceived gingival color improvement: Participants rated their perceived improvement in gingival color at 1,3 and 6 months post-treatment using a 5-point Likert scale: 0-4 scale: 0: no improvement, 1: little improvement, 2: average improvement, 3: great improvement, 4: Complete improvement Perceived gingival color improvement: Participants rated their perceived improvement in gingival color at 1,3 and 6 months post-treatment using a 5-point Likert scale: 0-4 scale: 0: no improvement, 1: little improvement, 2: average improvement, 3: great improvement, 4: Complete improvement (4C)Overall patient satisfaction: It reflected participant's overall treatment experience considering gingival color improvement, pain, itching, discomfort, intra- and post-operative bleeding, interference with routine oral activities, number of treatment visits and experience of undergoing a surgical or non -surgical procedure. Satisfaction was assessed at 1,3 and 6 months post-treatment using a 5-point Likert scale 0-4 scale: 0: very dissatisfied, 1: dissatisfied, 2: neither satisfied nor dissatisfied, 3: satisfied, 4: very satisfied Overall patient satisfaction: It reflected participant's overall treatment experience considering gingival color improvement, pain, itching, discomfort, intra- and post-operative bleeding, interference with routine oral activities, number of treatment visits and experience of undergoing a surgical or non -surgical procedure. Satisfaction was assessed at 1,3 and 6 months post-treatment using a 5-point Likert scale 0-4 scale: 0: very dissatisfied, 1: dissatisfied, 2: neither satisfied nor dissatisfied, 3: satisfied, 4: very satisfied Outcome measures The primary outcome of the study was the change in DOPI from baseline to 1-month post-treatment. Secondary outcomes included changes in GPI, PSA, L and GMMS at 1 month, repigmentation assessed using the above pigmentation parameters at 3 and 6 months, and PROMs comprising pain, itching, discomfort, perceived gingival color improvement, and overall patient satisfaction. Exploratory outcomes included changes in GT and the correlation between DMMS and GMMS. Treatment procedures All participants underwent full mouth supragingival and subgingival oral prophylaxis. Gingival depigmentation was performed in the maxillary esthetic zone extending from the first/second premolar to the same on the contralateral side by a single experienced periodontist (AD). Following baseline assessment of all parameters, participants received one of the following treatments according to the allocated groups: Scalpel technique: Local infiltration (2% lignocaine containing 1:80,000 adrenaline) was administered. Using a No.15C blade, a partial thickness incision was made parallel to the long axis of the tooth to remove the hyperpigmented epithelium and a thin layer of connective tissue while avoiding bone exposure (Fig. 1g). Residual tissue tags were trimmed using microsurgical scissors to ensure complete removal of visible pigmentation (Fig. 1h). The site was irrigated with saline, and hemostasis was achieved with sterile gauze. Participants were advised to avoid brushing the surgical site and use analgesics as required and were reviewed at 1-week post-surgery(Fig. 1i). MN + AA: A 1-mm layer of 20% benzocaine topical anesthetic gel (Progel-B, Septodent India) was applied to the target region. GT at each tooth was measured as described previously. The treatment was performed using an automated microneedling pen (Dr Pen auto microneedling system Ultima M8, China), with provision to adjust needle depth (0.25-2.5 mm) and fitted with a 16-pin stainless steel needle cartridge (0.18 mm needle diameter), in conjunction with topical AA solution (V-C injections, Vesco pharmaceuticals, Thailand) (Fig. 2a–c). The protocol adopted for gingival MN was similar to previous studies.17,19,23,24 The MN pen was operated at a low speed (level 1) of approximately 8000 RPM and needle penetration depth was set one increment lower than the measured pre-procedural GT at each tooth (0.25 mm for GT ≤ 0.5 mm, 0.5 mm for GT > 0.5-1 mm,1 mm for GT > 1-1.5 mm, and 1.5 mm for GT > 1.5-2.0 mm), to minimize the risk of overpenetration. Additional infiltration anesthesia (2% lignocaine containing 1:80,000 adrenaline) was administered when required. The device was applied perpendicular to the gingiva, using a stamping motion with about four to five overlapping passes across horizontal, vertical, and diagonal directions for 30-40 seconds per tooth, until uniform pinpoint bleeding points were achieved throughout the pigmented gingiva (Fig. 2d and e). The area was irrigated with saline. One ampoule of AA solution (1000 mg/5 mL) was dispended into a sterile steel bowl for use across the entire pigmented region per session. A cotton roll soaked in the AA solution was applied to the target pigmented site for 10 min (Fig. 2f and g). The needle cartridge was discarded after each treatment session. The procedure was repeated at a 1-week interval for three sessions, with participants reviewed at 1-week post-treatment completion (Fig. 2h and i) They were advised to avoid acidic, spicy, and highly pigmented foods and to take analgesics as required.Fig. 2Clinical steps of gingival depigmentation using the microneedling and ascorbic acid technique (MN + AA): (a) Baseline maxillary gingival pigmentation; (b)Armamentarium comprising the automated microneedling pen, disposable needle cartridge and ascorbic acid ampoule; (c) Disposable 16-pin stainless steel needle cartridge; (d)Microneedling pen placed on pigmented gingiva; (e)Pinpoint bleeding points following microneedling; (f) Ascorbic acid solution dispensed in a sterile steel bowl with cotton roll saturated with the solution; (g) Saturated cotton roll placed over the treated gingiva for 10 min; (h) Clinical appearance at 1week following the first treatment session; (i) Clinical appearance at 1 week following completion of three treatment sessions. Clinical steps of gingival depigmentation using the microneedling and ascorbic acid technique (MN + AA): (a) Baseline maxillary gingival pigmentation; (b)Armamentarium comprising the automated microneedling pen, disposable needle cartridge and ascorbic acid ampoule; (c) Disposable 16-pin stainless steel needle cartridge; (d)Microneedling pen placed on pigmented gingiva; (e)Pinpoint bleeding points following microneedling; (f) Ascorbic acid solution dispensed in a sterile steel bowl with cotton roll saturated with the solution; (g) Saturated cotton roll placed over the treated gingiva for 10 min; (h) Clinical appearance at 1week following the first treatment session; (i) Clinical appearance at 1 week following completion of three treatment sessions. Notably, the scalpel group underwent a single session of depigmentation procedure, while those in the MN + AA group received three treatment sessions at 1-week intervals. Both groups were reviewed 1 week after treatment completion, and subsequently followed up and assessed at 1, 3 and 6 months post-treatment completion. Statistical analysis Data were entered in an excel spreadsheet (Microsoft Corp, Washington, USA) and analyzed using Stata 18.0 statistical software (Stata Corp, TX, USA). Categorical data were presented using frequencies and percentages, and continuous variables as mean ± standard deviation (SD) or median and interquartile range (IQR), depending on data distribution. Between-group comparisons were performed using the chi-Square test or Fisher's exact test for categorical variables and the independent sample t-test or a Mann-Whitney U test for continuous variables. Changes over time and the group-by-time interactions were analyzed using generalized estimating equations (GEE) with Gaussian family, identity link functions, exchangeable correlation and robust standard errors. Within-group changes over time were assessed using GEE analysis followed by post hoc pairwise comparison with a Bonferroni correction. The correlations were assessed using Spearman's correlation coefficient. The primary outcome was analyzed at 1month using both per-protocol (PP; scalpel: n = 12, MN + AA: n = 11) and intention-to-treat (ITT; scalpel: n = 13, MN + AA: n = 13) approaches. To perform ITT, missing outcome data were filled using the last last-digit-carried forward (LOCF) method. The between group differences of primary and all secondary outcomes at 1 month time point were obtained using appropriate technique. A P-value <0.05 was considered statistically significant. Results Of the 26 enrolled participants, 23 were included in the analysis. One participant in each group was lost to follow-up at 6 months, while, one additional participant in the MN + AA group discontinued treatment due to an adverse event (Fig. 3). The patient developed a localized gingival abscess at the right maxillary canine, which developed a day after first session and was reported on day 3. This was the only adverse event recorded during the study, and was managed by local debridement under local anesthesia, with complete resolution by 1 week (Fig. S1).Fig. 3CONSORT (Consolidated Standards of Reporting Trials) flow chart showing the study layout. CONSORT (Consolidated Standards of Reporting Trials) flow chart showing the study layout. Baseline demographic and dermal pigmentation parameters were comparable between the groups (P > 0.05, Table 1). Intergroup comparisons of gingival pigmentation parameters at each follow-up time points (PP analysis) are presented in Table 2; with ITT and PP analyses at 1 month provided in Table S1. Both analyses showed significant intergroup differences for the primary outcome DOPI, as well as GMMS, GPI, and PSA, whereas the L was significant only in the PP analysis. Representative clinical photographs for the scalpel (Fig. 4a–e) and the MN + AA groups (Fig. 4f–j) at baseline and follow-ups illustrate these findings. The scalpel group achieved near complete depigmentation by 1 week and 1 month, whereas residual pigmentation persisted at a few anatomically challenging gingival sites for MN + AA (Fig. 5a–e). Repigmentation was observed in both groups at 3 and 6 months. DOPI and GMMS remained significantly lower in the scalpel group at 3 months, while only DOPI differed at 6 months (P < 0.05). No other pigmentation parameters showed significant inter-group differences during follow-up. GEE analysis demonstrated a significant overall treatment effect for DOPI across time points, with a mean reduction of 0.464 units (95% CI: −0.682 to −0.247) (Table 2). Intragroup analysis showed a significant reduction (P < 0.05) in all gingival pigmentation parameters for both the groups from baseline to 1 month, sustained at 3 and 6 months (Table S2).Table 1Baseline characteristics of the study participants in the two groups.Table 1Scalpel group (n = 12)MN + AA group (n = 11)Age in yearsa22.0 ± 3.5120.9 ± 2.70Gender(n(%)) Male3 (25)1 (9.09) Female9 (75)10 (90.91)Flitzpatrick skin type(n(%)) II2 (16.67)0(0) III7 (58.33)8(72.73) IV3 (25.00)3(27.27)DOPIa1.92 ± 0.552.02 ± 0.44GPIb3 (3, 3)3 (2.5,3)La46.22 ± 5.6847.90 ± 5.94PSAb1347.54 ± 435.051885.35 ± 765.86GMMSa49.74 ± 15.548.41 ± 16.00DMMSa43.93 ± 8.7941.01 ± 10.84GTa1.18 ± 0.231.19 ± 0.20aMN + AA: Microneedling with topical Ascorbic Acid, DOPI: Dummett oral Gupta Index; GPI: Gingival pigmentation index; PSA: Pigmented Surface Area; L:Lightness; GMMS: Gingival melanin meter score; GT: Gingival thickness; SD: standard deviation; data presented as mean ± standard deviation (SD).bdata presented as median (P25-P75) where P25 is 25th percentile and p75 is 75th percentile; groups were comparable at baseline.P<0.05 is statistically significantTable 2Intergroup comparisons of gingival pigmentation parameters at various timepoints.Table 2VariablesGroupsBaseline1month3 month6 monthsOverall mean difference (95% Confidence Interval)‡DOPIaScalpel2.02 ± 0.440.31 ± 0.150.71 ± 0.240.89 ± 0.31−0.464 (−0.682, −0.247)MN + AA1.92 ± 0.550.92 ± 0.271.10 ± 0.351.27 ± 0.35P value0.62<0.00010.0050.01GPIbScalpel3 (2.5,3)1 (1, 1)1 (1, 1.5)1 (1, 2)−0.42 (−0.70, −0.15)MN + AA3 (3, 3)1 (1, 2)1 (1, 2)2 (1, 2)P value0.9990.0270.880.54LaScalpel47.90 ± 5.9458.28 ± 2.6056.84 ± 3.5855.60 ± 4.451.75 (−0.443, 3.950)MN + AA46.22 ± 5.6855.40 ± 3.3354.81 ± 3.2355.25 ± 3.71P value0.490.030.160.84PSAbScalpel1885.35 ± 765.86197.02 ± 148.44297.68 ± 159.44373 ± 295.78−135.20 (−403.84, 133.44)MN + AA1347.54 ± 435.05510.67 ± 313.98561.97 ± 315.95548.28 ± 398.36P value0.060.020.310.52GMMSaScalpel48.41 ± 16.009.40 ± 5.6618.13 ± 7.1925.78 ± 6.94−9.42 (−15.2, −3.63)MN + AA49.74 ± 15.521.31 ± 8.8727.48 ± 8.3532.79 ± 10.10P value0.840.0090.00890.06MN + AA: Microneedling with topical Ascorbic Acid, DOPI: Dummett oral Gupta index, GMI: Gingival melanin index, L: Lightness, PSA: Pigmented Surface Area, GMMS: Gingival melanin meter score; a: data presented as mean ± standard deviation (SD), bdata presented as median (P25-P75) where P25 is 25th percentile and p75 is 75th percentile Obtained using Generalized Estimating Equation using data at 1 month, 3 months, and 6 months. The overall mean difference of DOPI, GPI, L, PSA, GMMS were estimated using Gaussian, identity link function and exchangeable correlation structure.P<0.05 is considered statistically significant.Fig. 4Representative cases demonstrating gingival pigmentation changes following Scalpel depigmentation:(a) Baseline; (b)1-weekpost-procedure; (c)1-month follow-up; (d)3-month follow-up; (e) 6-month follow-up, and Microneedling with ascorbic acid (MN+AA): (f) Baseline; (g)1- week post-treatment; (h) 1-month follow-up; (i) 3-month follow-up; (j) 6- months follow-up.Fig. 5Representative clinical images demonstrating anatomical limitations of the microneedling pen during gingival depigmentation:(a)Baseline gingival pigmentation in patient 1; (b)Difficulty in positioning the microneedling pen within the interdental gingiva between malposed tooth #11andtooth#12; (c) Post-operative view showing residual pigmentation in the interdental gingiva between the maxillary central incisors; (d) Baseline gingival pigmentation in patient 2; (e)Post-operative view demonstrating complete depigmentation of the buccal gingiva with residual pigmentation in difficult-to-access interdental papillary regions. Table 1Baseline characteristics of the study participants in the two groups.Table 1Scalpel group (n = 12)MN + AA group (n = 11)Age in yearsa22.0 ± 3.5120.9 ± 2.70Gender(n(%)) Male3 (25)1 (9.09) Female9 (75)10 (90.91)Flitzpatrick skin type(n(%)) II2 (16.67)0(0) III7 (58.33)8(72.73) IV3 (25.00)3(27.27)DOPIa1.92 ± 0.552.02 ± 0.44GPIb3 (3, 3)3 (2.5,3)La46.22 ± 5.6847.90 ± 5.94PSAb1347.54 ± 435.051885.35 ± 765.86GMMSa49.74 ± 15.548.41 ± 16.00DMMSa43.93 ± 8.7941.01 ± 10.84GTa1.18 ± 0.231.19 ± 0.20aMN + AA: Microneedling with topical Ascorbic Acid, DOPI: Dummett oral Gupta Index; GPI: Gingival pigmentation index; PSA: Pigmented Surface Area; L:Lightness; GMMS: Gingival melanin meter score; GT: Gingival thickness; SD: standard deviation; data presented as mean ± standard deviation (SD).bdata presented as median (P25-P75) where P25 is 25th percentile and p75 is 75th percentile; groups were comparable at baseline.P<0.05 is statistically significant Baseline characteristics of the study participants in the two groups. MN + AA: Microneedling with topical Ascorbic Acid, DOPI: Dummett oral Gupta Index; GPI: Gingival pigmentation index; PSA: Pigmented Surface Area; L:Lightness; GMMS: Gingival melanin meter score; GT: Gingival thickness; SD: standard deviation; data presented as mean ± standard deviation (SD). data presented as median (P25-P75) where P25 is 25th percentile and p75 is 75th percentile; groups were comparable at baseline.P<0.05 is statistically significant Table 2Intergroup comparisons of gingival pigmentation parameters at various timepoints.Table 2VariablesGroupsBaseline1month3 month6 monthsOverall mean difference (95% Confidence Interval)‡DOPIaScalpel2.02 ± 0.440.31 ± 0.150.71 ± 0.240.89 ± 0.31−0.464 (−0.682, −0.247)MN + AA1.92 ± 0.550.92 ± 0.271.10 ± 0.351.27 ± 0.35P value0.62<0.00010.0050.01GPIbScalpel3 (2.5,3)1 (1, 1)1 (1, 1.5)1 (1, 2)−0.42 (−0.70, −0.15)MN + AA3 (3, 3)1 (1, 2)1 (1, 2)2 (1, 2)P value0.9990.0270.880.54LaScalpel47.90 ± 5.9458.28 ± 2.6056.84 ± 3.5855.60 ± 4.451.75 (−0.443, 3.950)MN + AA46.22 ± 5.6855.40 ± 3.3354.81 ± 3.2355.25 ± 3.71P value0.490.030.160.84PSAbScalpel1885.35 ± 765.86197.02 ± 148.44297.68 ± 159.44373 ± 295.78−135.20 (−403.84, 133.44)MN + AA1347.54 ± 435.05510.67 ± 313.98561.97 ± 315.95548.28 ± 398.36P value0.060.020.310.52GMMSaScalpel48.41 ± 16.009.40 ± 5.6618.13 ± 7.1925.78 ± 6.94−9.42 (−15.2, −3.63)MN + AA49.74 ± 15.521.31 ± 8.8727.48 ± 8.3532.79 ± 10.10P value0.840.0090.00890.06MN + AA: Microneedling with topical Ascorbic Acid, DOPI: Dummett oral Gupta index, GMI: Gingival melanin index, L: Lightness, PSA: Pigmented Surface Area, GMMS: Gingival melanin meter score; a: data presented as mean ± standard deviation (SD), bdata presented as median (P25-P75) where P25 is 25th percentile and p75 is 75th percentile Obtained using Generalized Estimating Equation using data at 1 month, 3 months, and 6 months. The overall mean difference of DOPI, GPI, L, PSA, GMMS were estimated using Gaussian, identity link function and exchangeable correlation structure.P<0.05 is considered statistically significant. Intergroup comparisons of gingival pigmentation parameters at various timepoints. MN + AA: Microneedling with topical Ascorbic Acid, DOPI: Dummett oral Gupta index, GMI: Gingival melanin index, L: Lightness, PSA: Pigmented Surface Area, GMMS: Gingival melanin meter score; a: data presented as mean ± standard deviation (SD), bdata presented as median (P25-P75) where P25 is 25th percentile and p75 is 75th percentile Obtained using Generalized Estimating Equation using data at 1 month, 3 months, and 6 months. The overall mean difference of DOPI, GPI, L, PSA, GMMS were estimated using Gaussian, identity link function and exchangeable correlation structure.P<0.05 is considered statistically significant. Representative cases demonstrating gingival pigmentation changes following Scalpel depigmentation:(a) Baseline; (b)1-weekpost-procedure; (c)1-month follow-up; (d)3-month follow-up; (e) 6-month follow-up, and Microneedling with ascorbic acid (MN+AA): (f) Baseline; (g)1- week post-treatment; (h) 1-month follow-up; (i) 3-month follow-up; (j) 6- months follow-up. Representative clinical images demonstrating anatomical limitations of the microneedling pen during gingival depigmentation:(a)Baseline gingival pigmentation in patient 1; (b)Difficulty in positioning the microneedling pen within the interdental gingiva between malposed tooth #11andtooth#12; (c) Post-operative view showing residual pigmentation in the interdental gingiva between the maxillary central incisors; (d) Baseline gingival pigmentation in patient 2; (e)Post-operative view demonstrating complete depigmentation of the buccal gingiva with residual pigmentation in difficult-to-access interdental papillary regions. Low post-operative pain, itching and discomfort scores (VAS: 0-3.5) were observed in both groups. Discomfort scores were consistently higher in the scalpel group, though a significant difference was observed only on postoperative day 3 (Fig. 6a). In the MN + AA group, six participants required additional infiltration anesthesia, while five completed the procedure with topical anesthesia alone. Perceived color improvement and overall treatment satisfaction remained high throughout follow-up in both groups (median score 3-4 and 4, respectively; Fig. 6b and c). GT was significantly greater in the MN + AA group at 6 months (P < 0.05), with no significant differences at 1 or 3 months (Table S3). Baseline DMMS did not correlate significantly with GMMS at any timepoint (Table S4).Fig. 6Patient-reported outcome measures (PROMs) in the scalpel and Microneedling with ascorbic acid (MN + AA) groups: (a)Post-operative pain, itching and discomfort scores during the first post-operative week; (b) Perceived gingival color improvement at 1,3 and 6 months post-treatment; (c) Overall treatment satisfaction at 1, 3 and 6 months post-treatment. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.) Patient-reported outcome measures (PROMs) in the scalpel and Microneedling with ascorbic acid (MN + AA) groups: (a)Post-operative pain, itching and discomfort scores during the first post-operative week; (b) Perceived gingival color improvement at 1,3 and 6 months post-treatment; (c) Overall treatment satisfaction at 1, 3 and 6 months post-treatment. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.) Discussion With the growing interest in minimally invasive approaches for gingival depigmentation, the present study compared the MN + AA with the scalpel technique for their depigmentation efficacy, PROMs, and repigmentation. Additionally, this is the first gingival depigmentation study to quantify both gingival and dermal melanin concentrations using a dermal melanin meter. These devices are employed in dermatology as non-invasive reflectance-based instruments that provide objective, reproducible quantification of epidermal melanin concentration and have been validated for monitoring treatment responses across pigmentary disorders.25 Objective gingival melanin assessment was incorporated in the current study as clinical indices are inherently subjective, and photographic assessments are influenced by lighting conditions, gingival hue, and examiner perception.26,27 Both modalities significantly reduced gingival pigmentation at 1 month; however, the scalpel group showed significantly greater improvement in both pigmentation intensity (DOPI, L*, GMMS) and extent (GPI, PSA). The 1-month timepoint was selected in accordance with previous MN and AA studies, allowing completion of re-epithelialization and stabilization of clinical color outcomes.1,7,10,11,15,19 While scalpel depigmentation immediately removes the pigmented epithelium in a single session, depigmentation with MN + AA may result from enhanced transepithelial delivery of AA combined with MN-induced epithelial remodeling. Potential mechanisms include regulation of melanosome transfer, transient basement membrane disruption facilitating melanin clearance, and accelerated epithelial turnover. The additional gain in GT may further reduce the clinical visibility of residual pigmentation.15,28 These synergistic effects of MN and AA observed in the current study are consistent with the findings of Mosby et al..and Maheshwari et al., who reported superior depigmentation with the scalpel technique, but differ from those of a split-mouth trial favoring MN + AA 15,17, 18, 19, 20. These differences may be attributable to variations in MN pen design, needle number and diameter, and AA formulation. Unlike previous studies using freshly prepared AA powder, current study employed a ready-to-use, standardized ampoule requiring no chair-side preparation. Notably, residual pigmentation was observed at few anatomically challenging gingival sites following MN + AA, possibly due to the limited adaptation of dermatology-based MN pen's needle cartridge and straight handpiece to narrow interdental papillae and premolar gingiva. In contrast, the scalpel technique allowed direct visualization and complete pigment removal from these sites. Repigmentation occurred following both treatment modalities, howeverthe scalpel group maintained lower DOPI at 3 and 6 months, likely reflecting more complete elimination of melanocyte-containing basal epithelium. Pigmentation extent (GPI, PSA), however, was comparable between groups during follow-up, suggesting that limited migration and proliferation of residual or adjacent melanocytes, the most widely accepted mechanism of repigmentation, may restore the pigmentation regardless of the technique.1,29 In addition, surgical procedure-induced inflammation and wound healing may stimulate melanogenesis through upregulation of cytokines and growth factors contributing to post-inflammatory pigmentation.30 PROMs were favorable in both groups. Pain, itching, and discomfort scores were modestly higher following scalpel depigmentation, reaching significance only for discomfort on day 3.Although previous studies have reported greater post-operative morbidity with the scalpel technique than with minimally invasive approaches such as MN, injectable AA, and laser therapy,1,3,15,19 our findings suggest that scalpel depigmentation was also well tolerated. Compared with injectable AA delivered through conventional hypodermic needle, MN + AA provides controlled transepithelial drug delivery through uniform microchannels, which may reduce localized deposition at discrete sites thus minimizing tissue distention, irritation or ulceration.30 Consistent with this, itching scores were low, contrasting with our previous preliminary case series of injectable AA, in which few participants experienced itching and ulceration.11 Furthermore, shallow MN penetration depths (<700 μm) avoid deeper vascular and neural structures while effectively breaching the epithelial barrier, which may explain why topical anesthesia alone was sufficient for some participants. Notably, one participant in the MN + AA group presented with a localized gingival abscess the day after the first session possibly related to localized tissue trauma, microbial ingress in microneedling channels, or local irritant reaction to AA. An overall PROMs were favorable for MN + AA, however, these findings are based on the first session only, consistent with the assessment window used in comparable previous studies,10,11,19 and should be interpreted accordingly. Further,this solitary adverse event also highlights the importance of post-operative monitoring and further safety evaluation of dermatology-based MN pen for gingival use. From the patient's perspective, color improvement remained high in both groups throughout follow-up, despite incomplete depigmentation in some MN + AA cases and evidence of repigmentation. This suggests that patients may prioritize overall esthetic improvement, procedural comfort, and the minimally invasive treatment over complete pigment elimination. MN + AA showed favorable tolerability and satisfaction despite requiring three sessions, however, this unequal treatment exposure should be considered when interpreting efficacy relative to the single session scalpel depigmentation. Overall, no single technique is universally ideal, and treatment selection should be individualized. Scalpel therapy offers nearly complete cost-effective pigment removal, whereas MN + AA may provide additional gingival augmentation with favorable patient acceptance but requires specialized equipment, and recurring disposable cartridge costs. Thus, treatment modality for gingival depigmentation should be selected considering pigmentation intensity and extent, GT clinician's experience, available resources, and the patient's preferences. GT was evaluated as an exploratory outcome and has not previously been assessed in MN-based gingival depigmentation trials. Both groups demonstrated a progressive increase in GT over time, reaching significance in MN + AA group at 6 months. The change in the scalpel group likely reflected normal wound healing, whereas the additional gain in the MN + AA group may be attributed to the biological effects of microneedling. Platelet activation, release of growth factors, fibroblast migration, and proliferation, neocollagenesis, and neovascularization may promote collagen induction in gingiva, similar to skin 14. Histologic studies in dermatology have demonstrated increased epidermal thickness and sustained collagen remodeling for up to 6 months following MN, with continued tissue maturation thereafter.13,14 Collagen-promoting effects of AA can further contribute to increased tissue thickness. These results are consistent with recent reports of increased GT following MN-based procedures.11,31 Such additional GT augmentation may be particularly relevant to thin gingival phenotypes, though potential benefit warrants confirmation in future studies supported by histologic and volumetric evaluation. Constitutional dermal pigmentation is believed to be associated with baseline gingival pigmentation, commonly assessed using the visual Fitzpatrick skin phototype.32 To our knowledge, current study, for the first time explored, an association between baseline dermal melanin pigmentation and gingival pigmentation outcomes at different timepoints. Dermal melanin concentration was assessed objectively using the MILO melanin meter at the malar regions, a standardized facial site representative of visible facial complexion.33 The absence of a significant dermal-gingival (DMMS-GMMS) correlation at any follow-up timepoint, suggests that constitutional pigmentation may not be a major determinant of treatment outcomes. Other factors such as completeness of pigment removal, melanocyte migration from adjacent tissues, wound-healing dynamics, and local inflammatory mediators may play a greater role, although this warrants further investigation. Strengths of the present study include objective melanin quantification using a melanin meter, combined PP and ITT analyses to enhance the assessment of depigmentation efficacy, documentation of PROMs, and anatomical limitations associated with the MN device. Exploration of GT and dermal-gingival associations further provide an insights beyond depigmentation efficacy alone. Limitations include a short follow-up period, exclusion of participants with missing data, multiple secondary comparisons, and limited validation of the melanin meter for gingival use with occasional challenges in measuring gingival melanin due to its large probe aperture. Possible assessor unblinding cannot be excluded, given visually distinguishable differences between interventions. The absence of AA-only or MN-only arms limit the ability to determine each component's individual contribution to the observed outcomes. Generalizability is limited to systemically healthy, non-smoking individuals with physiologic melanin pigmentation. Although this study has sufficient a priory and post hoc power, the finding should be interpreted with caution and validated in larger samples. Conclusion Within limitations of the study, both treatments significantly reduced gingival pigmentation at 1 month. The scalpel technique showed greater improvement in pigmentation intensity and extent and maintained lower pigmentation intensity at 6 months, though both groups showed repigmentation. Both treatments were well tolerated with favorable PROMs. The greater increase in GT observed with MN + AA and the absence of an association between baseline dermal and gingival pigmentation outcomes require confirmation in further studies. Future studies should incorporate longer follow-up and be directed towards developing gingival-specific microneedling devices and adjunctive therapies to delay repigmentation. Informed consent Written informed consent was obtained from all participants. Author contributions Conceptualization: AD; Data curation: AD, JP, VSY, DA, AI, RH; Investigation: AD, JP, VSY, DA; Methodology:AD, JP, VSY; Project Administration: AD; Resources: JP, DA, SKD, AI; Vizualization: AD, JP, DA; Supervision: AD, VSY; Validation: AD, VSY, SKD; Formal analysis: SKD, AD; Software: SKD, DA, AI, RH; Writing original draft: AD; Writing reviewing and editing: JP, VSY, DA, SKD, AI, RH. Ethical statement Ethical approval (AIIMSA1242/22.4.24) was granted by the institute's ethical committee on human subjects after explaining study design., Data statement The data that supports the findings of the study will be available from the corresponding author upon request. Funding No funding received; self-funded by authors. Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.